AETERNA ZENTARIS GMBH

 AETERNA ZENTARIS GMBH contact information is shown below
Owner:AETERNA ZENTARIS GMBH
Owner Address:Weismüllerstrasse 50 Frankfurt am Main 60314 Germany
Owner Web Site
Owner Phone
Owner Toll Free
Owner Fax

 

Brands Owned byAETERNA ZENTARIS GMBH

Brand:

CETROTIDE

Description:

pharmaceutical preparations for the treatment of gynecological disorders, fertility problems [, cancer, and urological disorders];

Category: PHARMACEUTICAL PREPARATIONS TREATMENT
Brand:

KRONEXTA

Description:

Pharmaceutical preparations used for the treatment of cancer, pharmaceutical preparations administered as a radiosensitizer and used for the treatment of cancer, pharmaceutical preparations used for the treatment of urological diseases, pharmaceutical preparations used for the treatment of hormonal disorders, peptides-containing pharmaceutical preparations used for hormonal and tumors treatments, pharmaceutical preparations used for the treatment of endocrine diseases, pharmaceutical preparations used for the treatment of carcinoid tumors, pharmaceutical preparations used for the treatment of age-related diseases, pharmaceutical preparation used for the treatment of endometriosis, pharmaceutical preparations used for the treatment of uterine myoma, pharmaceutical preparations used for the treatment of non-malignant tumors, pharmaceutical preparation used for the treatment for begnin prostatic hyperplasia BPH, pharmaceutical preparations used as a tubulin inhibitor, pharmaceutical preparations based on LHRH antagonists platform, pharmaceutical preparations based on angiogenesis inhibitors platform, pharmaceutical preparations used to induce apoptosis;

Category: PHARMACEUTICAL PREPARATIONS USED
Brand:

KRONEXTA

Description:

Pharmaceutical compositions for use in cancer treatments;

Category: PHARMACEUTICAL COMPOSITIONS USE
Brand:

LEXURA

Description:

Pharmaceutical preparations used for the treatment of cancer, pharmaceutical preparations administered as a radiosensitizer and used for the treatment of cancer, pharmaceutical preparations used for the treatment of urological diseases, pharmaceutical preparations used for the treatment of hormonal disorders, peptides-containing pharmaceutical preparations used for hormonal and tumors treatments, pharmaceutical preparations used for the treatment of endocrine diseases, pharmaceutical preparations used for the treatment of carcinoid tumors, pharmaceutical preparations used for the treatment of age-related diseases, pharmaceutical preparation used for the treatment of endometriosis, pharmaceutical preparations used for the treatment of uterine myoma, pharmaceutical preparations used for the treatment of non-malignant tumors, pharmaceutical preparation used for the treatment for begnin prostatic hyperplasia BPH, pharmaceutical preparations used as a tubulin inhibitor, pharmaceutical preparations based on LHRH antagonists platform, pharmaceutical preparations based on angiogenesis inhibitors platform, pharmaceutical preparations used to induce apoptosis;

Category: PHARMACEUTICAL PREPARATIONS USED
Brand:

LEXURIS

Description:

Pharmaceutical preparations used for the treatment of cancer, pharmaceutical preparations administered as a radiosensitizer and used for the treatment of cancer, pharmaceutical preparations used for the treatment of urological diseases, pharmaceutical preparations used for the treatment of hormonal disorders, peptides-containing pharmaceutical preparations used for hormonal and tumors treatments, pharmaceutical preparations used for the treatment of endocrine diseases, pharmaceutical preparations used for the treatment of carcinoid tumors, pharmaceutical preparations used for the treatment of age-related diseases, pharmaceutical preparation used for the treatment of endometriosis, pharmaceutical preparations used for the treatment of uterine myoma, pharmaceutical preparations used for the treatment of non-malignant tumors, pharmaceutical preparation used for the treatment for benign prostatic hyperplasia (BPH), pharmaceutical preparations used as a tubulin inhibitor, pharmaceutical preparations based on LHRH antagonists platform for the treatment of cancer, cancer in combination with administered radiosensitizing, urological diseases, hormonal disorders, hormonal and tumor disorders, endocrine diseases,carcinoid tumors, age-related diseases, endometriosis, uterine myoma, non-malignant tumors and benign prostatic hyperplasia; pharmaceutical preparations used to induce apoptosis;

Category: PHARMACEUTICAL PREPARATIONS USED
Brand:

LEXURIS

Description:

Pharmaceutical compositions for use in cancer treatments;

Category: PHARMACEUTICAL COMPOSITIONS USE
Brand:

MACRILEN

Description:

Diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency;Medical and veterinary services, namely, medical testing for the diagnosis of growth hormone deficiency;Medical and scientific research in the field of medicine and medical diagnostics;

Category: DIAGNOSTIC PREPARATIONS MEDICAL USE
Brand:

MACRILEN

Description:

The mark consists of three triangle type designs forming a circle in front of the word Macrilen.;Diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency;Color is not claimed as a feature of the mark.;Medical and veterinary services, namely, medical testing for the diagnosis of growth hormone deficiency;Medical and scientific research in the field of medicine and medical diagnostics;

Category: